Results 261 to 270 of about 259,973 (292)

Clinical Significance of PD‐L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy

Annals of Gastroenterological Surgery, EarlyView.
This study evaluated immune‐related biomarkers in esophageal squamous cell carcinoma treated with immune checkpoint inhibitors after postoperative recurrence. PD‐L1 expression in tumor‐associated macrophages and tumor cells, together with HLA class I downregulation and HLA‐DR expression, were associated with favorable responses to immunotherapy.
Kosuke Kanemitsu, Yoshiyuki Tagayasu, Yoshihiro Komohara, Cheng Pan, Rin Yamada, Yukio Fujiwara, Kazuto Harada, Keisuke Kosumi, Yoshifumi Baba, Masaaki Iwatsuki   +9 more
wiley   +1 more source

AI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective

Advanced Intelligent Discovery, EarlyView.
The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.
Shilong Liu, Shunxiang Li, Kun Qian
wiley   +1 more source

Erratum: Ginseng-Derived Exosomes Attenuate Immune Evasion in NSCLC via PD-L1 Modulation [Corrigendum]. [PDF]

Cancer Manag Res
europepmc   +1 more source

CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis. [PDF]

Transl Oncol
Witzleben AV, Remark R, Idel C, Ribbat-Idel J, Krupar R, Schröck A, Klümper N, Doescher J, Sikora AG, Kors TA, Vahl JM, Brand M, Sonntag M, Brunner C, Hoffmann TK, Perner S, Gnjatic S, Laban S.   +17 more
europepmc   +1 more source

Mitofusin-2 suppresses tumor immune escape through EGFR/STAT3-mediated PD-L1 transcription. [PDF]

Cell Death Dis
Liu Y, Wang N, Li Z, Li N, Hui F, Wang X, Tang G, Zhang Q, Yu G, Liu S, Ding Y.   +10 more
europepmc   +1 more source

PD-L1 expression in schistosomal granuloma: an immunohistochemical study in urinary bladder schistosomiasis. [PDF]

J Clin Pathol
Elhalaby RE, Zeina WO, Nessim L, Ahmed ME, Kamel NN, Anis SE, Dong H, Cheville JC, Kwon ED.   +8 more
europepmc   +1 more source

IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapy. [PDF]

Antib Ther
Chen D, Wu Z, Zhao X, Bhatt RS, Yang Y, Zhu W, Tang H, Wang K, Guo C, Liu D, Yang C, Guo H, Bai X, Zhang R, Li S, Tian W.   +15 more
europepmc   +1 more source

PD-L1-negative triple-negative breast cancer exhibited a remarkable response to cadonilimab: a case report. [PDF]

Front Oncol
Chen B, Jia Y, Meng L, Hu N.
europepmc   +1 more source

Myeloid-derived PD-L1 characterizes spatially organized immune architecture in colorectal cancer. [PDF]

Front Immunol
Wu Q, Tissot S, Peddle A, Yin K, Sagaert X, De Hertogh G, Abdelkader B, Pu T, Van Herpe F, D'Hoore A, Rusakiewicz S, Verbandt S, Tejpar S, Rasschaert G.   +13 more
europepmc   +1 more source